Short-course blinatumomab as a bridge-to-transplantation improves the survival of Ph-negative MRD-positive B-ALL.

Cell Transplant · 2026 · PMC13342381 · PMID 42411267

Europe PMC DOI

hedged sentence

0.1500

closest p · 3.0× alpha

0.1500

boldest claim

The sentences

a borderline significant trendp = 0.15not close (p > 0.1)

A borderline significant trend towards superior OS ( p = 0.15) may reflect limited sample size and follow-up duration, which may attain statistical significance with extended follow-up and larger patient cohorts.

also in 231 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.